Stereotaxis System Procedure Featured on NBC's The TODAY Show

Tuesday, February 2, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+



ST. LOUIS, Feb. 1 Stereotaxis (Nasdaq: STXS) announced that NBC's The TODAY Show featured Dr. Mauricio Arruda, a leading electro-physiologist and Director of the University Hospitals Heart & Vascular Institute in Cleveland, Ohio, performing a live cardiac ablation procedure using a Stereotaxis system during its broadcast this morning. The patient was a 69 year old woman who suffered from a severe cardiac arrhythmia. The procedure was completed successfully.

The Stereotaxis system allows the physician to control the tip of the catheter by using magnetic fields, providing reduced radiation exposure, a low major adverse event rate and clinical results which mimic the best hands in the world.

The TODAY Show segment is available at http://bit.ly/cLSYg9. For more information on Stereotaxis, please visit www.stereotaxis.com.

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. Stereotaxis' Odyssey workstation integrates and standardizes data through a consolidated display of multiple systems, eliminating the challenge of interacting simultaneously with many separate diagnostic systems. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada.

SOURCE Stereotaxis


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook